{
    "Trade/Device Name(s)": [
        "Dimension\u00ae HB1C Kit",
        "Dimension\u00ae HB1C Calibrator",
        "HB1C Flex\u00ae reagent cartridges"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics Inc.",
    "510(k) Number": "K102510",
    "Predicate Device Reference 510(k) Number(s)": [
        "K070452"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP",
        "KRZ",
        "JJX"
    ],
    "Summary Letter Date": "April 5, 2011",
    "Summary Letter Received Date": "April 7, 2011",
    "Submission Date": "August 24, 2010",
    "Regulation Number(s)": [
        "21 CFR 864.7470"
    ],
    "Regulation Name(s)": [
        "Glycosylated Hemoglobin Assay"
    ],
    "Analyte Class(es)": [
        "hematology"
    ],
    "Analyte(s)": [
        "Hemoglobin A1c",
        "Total Hemoglobin"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [
        "EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "Dimension\u00ae clinical chemistry system (all models)"
    ],
    "Method(s)/Technology(ies)": [
        "Turbidimetric inhibition immunoassay (TINIA)",
        "Modified alkaline hematin reaction"
    ],
    "Methodologies": [
        "Immunoassay",
        "Chemistry"
    ],
    "Submission Type(s)": [
        "Kit",
        "Calibrator",
        "Reagent Cartridge"
    ],
    "Document Summary": "FDA 510(k) summary for Siemens Dimension\u00ae HB1C Kit for quantitative determination of hemoglobin A1c in human whole blood on Dimension\u00ae clinical chemistry systems",
    "Indications for Use Summary": "In vitro diagnostic assay for the quantitative determination of hemoglobin A1c in human anticoagulated whole blood to monitor long-term glucose control in individuals with diabetes mellitus",
    "fda_folder": "Hematology"
}